Millennium Management’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-55,644
| Closed | -$1.85M | – | 6689 |
|
|
2024
Q3 | $1.85M | Sell |
55,644
-114,199
| -67% | -$3.93M | ﹤0.01% | 3768 |
|
|
2024
Q2 | $4.59M | Sell |
169,843
-363,192
| -68% | -$7.16M | ﹤0.01% | 2805 |
|
|
2024
Q1 | $11.5M | Buy |
+533,035
| New | +$11.6M | ﹤0.01% | 2048 |
|
|
2023
Q4 | – | Sell |
-17,153
| Closed | -$95.4K | – | 6878 |
|
|
2023
Q3 | $95.4K | Buy |
+17,153
| New | +$110K | ﹤0.01% | 5355 |
|
|
2023
Q2 | – | Sell |
-1,047,705
| Closed | -$4.12M | – | 7149 |
|
|
2023
Q1 | $4.12M | Buy |
1,047,705
+59,993
| +6% | +$293K | ﹤0.01% | 2779 |
|
|
2022
Q4 | $3.12M | Sell |
987,712
-66,847
| -6% | -$268K | ﹤0.01% | 3189 |
|
|
2022
Q3 | $3.92M | Buy |
1,054,559
+11,343
| +1% | +$41.9K | ﹤0.01% | 3141 |
|
|
2022
Q2 | $3.22M | Sell |
1,043,216
-2,713
| -0.3% | -$12.5K | ﹤0.01% | 3224 |
|
|
2022
Q1 | $5.43M | Buy |
1,045,929
+820,372
| +364% | +$3.89M | ﹤0.01% | 2839 |
|
|
2021
Q4 | $1.09M | Buy |
+225,557
| New | +$1.53M | ﹤0.01% | 4332 |
|
|
2021
Q3 | – | Sell |
-54,443
| Closed | -$497K | – | 7672 |
|
|
2021
Q2 | $497K | Sell |
54,443
-135,906
| -71% | -$1.35M | ﹤0.01% | 5317 |
|
|
2021
Q1 | $3.11M | Buy |
+190,349
| New | +$3.11M | ﹤0.01% | 3106 |
|
Millennium Management's LBPH Position: Q4 2024 in Review
Millennium Management sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 55,644 shares — an estimated $1.85M sold.
Millennium Management first reported a position in LBPH in Q1 2021 and held it in 12 quarters. The position peaked at $11.5M in Q1 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.
- Millennium Management reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Millennium Management sold 55,644 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $1.85M.
- Millennium Management first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
- Millennium Management's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $11.5M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.
Based on Millennium Management's 13F filing for Q4 2024, filed 14 Feb 2025.